Literature DB >> 18487454

Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion.

Ren Liu1, Bo Tian, Marla Gearing, Stephen Hunter, Keqiang Ye, Zixu Mao.   

Abstract

Isoform A of phosphatidylinositol 3-kinase enhancer (PIKE-A) is a newly identified prooncogenic factor that has been implicated in cancer cell growth. How PIKE-A activity is regulated in response to growth signal is poorly understood. Here, we demonstrate that cyclin dependent kinase 5 (Cdk5), a protein known to function mainly in postmitotic neurons, directly phosphorylates PIKE-A at Ser-279 in its GTPase domain in glioblastoma cells. This phosphorylation event stimulates PIKE-A GTPase activity and the activity of its downstream effector Akt. Growth signal activates Cdk5 and results in a Cdk5-dependent accumulation of phosphorylated PIKE-A and activation of Akt in the nucleus. Furthermore, PIKE-A phosphorylation and Cdk5 are increased in human glioblastoma specimens. Phosphorylation of PIKE-A by Cdk5 mediates growth factor-induced migration and invasion of human glioblastoma cells. Together, these findings identify PIKE as the first Cdk5 target in cancer cells, revealing a previously undescribed regulatory mechanism that mediates growth signal-induced activation of PIKE-A/Akt and tumor invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487454      PMCID: PMC2396674          DOI: 10.1073/pnas.0712306105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5): modulation of cAMP-induced apoptosis in rat leukemia cells.

Authors:  Tone Sandal; Camilla Stapnes; Hans Kleivdal; Lars Hedin; Stein Ove Døskeland
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

2.  Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.

Authors:  Ho Lin; Mei-Chih Chen; Chih-Yuan Chiu; Yuh-Min Song; Shih-Yi Lin
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

3.  Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells.

Authors:  A Catania; S Urban; E Yan; C Hao; G Barron; J Allalunis-Turner
Journal:  Neuro Oncol       Date:  2001-04       Impact factor: 12.300

4.  Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N.

Authors:  K Ye; K J Hurt; F Y Wu; M Fang; H R Luo; J J Hong; S Blackshaw; C D Ferris; S H Snyder
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

5.  PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion.

Authors:  X Liu; Y Hu; C Hao; S A Rempel; K Ye
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

6.  Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.

Authors:  Shaun Goodyear; Mahesh C Sharma
Journal:  Exp Mol Pathol       Date:  2006-11-01       Impact factor: 3.362

7.  GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins.

Authors:  Chunzhi Xia; Wenbin Ma; Lewis Joe Stafford; Chengyu Liu; Liming Gong; James F Martin; Mingyao Liu
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Neuronal cyclin-dependent kinase 5 activity is critical for survival.

Authors:  T Tanaka; T Ohshima; P Rajan; N D Amin; A Cho; T Sreenath; H C Pant; R O Brady; A B Kulkarni
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

9.  Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin.

Authors:  Yuki Miyamoto; Junji Yamauchi; Jonah R Chan; Atsumasa Okada; Yasuhiro Tomooka; Shin-ichi Hisanaga; Akito Tanoue
Journal:  J Cell Sci       Date:  2007-11-27       Impact factor: 5.285

10.  Cdk5 mediates changes in morphology and promotes apoptosis of astrocytoma cells in response to heat shock.

Authors:  C Gao; S Negash; H S Wang; D Ledee; H Guo; P Russell; P Zelenka
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  57 in total

1.  Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7.

Authors:  Friedemann Zengerling; Anca Azoitei; Alexander Herweg; Florian Jentzmik; Marcus V Cronauer
Journal:  World J Urol       Date:  2015-08-29       Impact factor: 4.226

2.  RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5.

Authors:  Yuan Xiao Zhu; Rodger Tiedemann; Chang-Xin Shi; Holly Yin; Jessica E Schmidt; Laura A Bruins; Jonathan J Keats; Esteban Braggio; Chris Sereduk; Spyro Mousses; A Keith Stewart
Journal:  Blood       Date:  2011-02-02       Impact factor: 22.113

3.  Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models.

Authors:  Chaoxin Hu; Tikva Dadon; Venugopal Chenna; Shinichi Yabuuchi; Rajat Bannerji; Robert Booher; Peter Strack; Nilofer Azad; Barry D Nelkin; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2015-04-30       Impact factor: 6.261

4.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

5.  A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion.

Authors:  Manuela Quintavalle; Leonardo Elia; Jeffrey H Price; Susanne Heynen-Genel; Sara A Courtneidge
Journal:  Sci Signal       Date:  2011-07-26       Impact factor: 8.192

Review 6.  Cdk5: mediator of neuronal development, death and the response to DNA damage.

Authors:  Jinqiu Zhu; Wenming Li; Zixu Mao
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

Review 7.  Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

Authors:  Jenna M Gaesser; Sharyl L Fyffe-Maricich
Journal:  Exp Neurol       Date:  2016-03-05       Impact factor: 5.330

Review 8.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

9.  Proteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migration.

Authors:  Shuangbing Xu; Xu Li; Zihua Gong; Wenqi Wang; Yujing Li; Binoj Chandrasekharan Nair; Hailong Piao; Kunyu Yang; Gang Wu; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2014-08-05       Impact factor: 5.911

10.  Targeted therapy in the treatment of malignant gliomas.

Authors:  Rimas V Lukas; Adrienne Boire; M Kelly Nicholas
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.